Video: Dendritic Cells Activate an Immune Reaction Against the Tumor
Using Viruses Against Cancer
Certain oncolytic viruses can only multiply in tumor cells, destroying them in the process, while healthy cells can defend themselves against the virus. The Newcastle Disease Virus (NDV) is such a virus. It is totally harmless for humans: it exclusively multiplies in human tumor cells while not damaging healthy cells. Infected tumor cells send out danger signals, which alarm and activate the immune system. Thus NDV increases the effectiveness of IO-VAC®.
“Viruses are known as the cause of several illnesses. However, what is not so well known, is that certain viruses can be used for treating cancer. Over 100 years ago, doctors first observed that patients were healed from cancer after being infected with a certain virus.”
Prof. Dr. rer. nat. Volker Schirrmacher
This post is also available in: German
The IOZK Immunotherapy
- Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
- Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
- International Journal of Oncology: “From chemotherapy to biological therapy”, Prof. Dr. Volker Schirrmacher